What Happened?
, -based Recor Medical Appointed Douglas Schreiber as Director of Sales
About the Company
The RADIANCE-HTN Clinical study is a randomized, controlled study to evaluate the Paradise Renal Denervation System intended to treat high blood pressure. The study will be in up to 40 hospitals in 5 countries (US, France, Germany, The Netherlands, UK...
About the Person
Douglas Schreiber is Director of Sales at Recor Medical. Previously, Douglas held various senior HR leadership roles in the industry.
Info Source
News
Short Profile